Crossmark

The future of treating pancreatic exocrine insufficiency

Crossref DOI link: https://doi.org/10.1038/s41575-025-01150-z

Published Online: 2025-11-12

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Löhr, J.-Matthias https://orcid.org/0000-0002-7647-198X
Vujasinovic, Miroslav https://orcid.org/0000-0002-6496-295X
License Information

Text and Data Mining valid from 2025-11-12

Version of Record valid from 2025-11-12
More Information

Article History

First Online: 12 November 2025

Competing interests

: J.-M.L. and M.V. declare lecture honoraria from Abbott, Frostpharma, Nordmark and Viatris.